- Represented Vuelta Productions Limited, an Irish media production and distribution investment vehicle, on acquisitions in Denmark, Germany, France, and Italy.
- Represented Rhône Capital L.L.C., a transatlantic private equity fund, and its affiliated funds in its investment in Sweet Oak, leading to ownership of Royal Oak Enterprises, LLC, a manufacturer and distributor of fire building products, charcoal, artificial logs, matches, and lighter fluids and Whole Earth Brands, Inc., a manufacturer of plant-based sweeteners, flavor enhancers, and other foods. Also represented Rhône Capital in its acquisition of Rexair, the manufacturer and distributor of Rainbow® products for indoor environments from Newell Brands (Nasdaq: NWL).
- Represented the owners of Bansard International in the sale of Bansard, a global transport and logistics provider, to SEKO Logistics, a portfolio company of Ridgemont Equity Partners.
- Represented Seventh Avenue Investments LLC in connection with numerous equity and convertible debt investments in numerous sectors, including integrated cannabis companies (multistate and publicly traded operators).
- Represented Volery Capital Partners, a U.S. private equity fund focused on investments in the financial services industry, in numerous equity and debt investments.
- Represented Great Mountain Partners, a U.S. asset manager, in the creation of a pan-European media platform and the acquisition of media production and distribution companies in the Nordics, Germany, and other E.U. countries.
- Represented Ortho Dev America and its parent company, Eqwal Group, in numerous acquisitions of orthopedic & prosthetic clinics across the U.S., as well as the creation of its U.S. platform.
- Represented Anjac Health & Beauty, a French industrial group, in its acquisition of Cosmetix West, a California manufacturer of cosmetics, drugs, and food supplements.
- Represented HR Path, a global specialist in human resource solutions, in its first acquisition in the U.S., of Exaventures.
- Represented Radiall America Inc., a U.S. subsidiary of the French group, Radiall SA, in its acquisition of Timbercon Inc., a U.S. manufacturer of fiber optic and hybrid solutions for the military, aerospace, data communications, medical, and industrial markets.
- Represented Petit Forestier Group, European leader in refrigeration rental, in its first U.S. acquisition of Mendon Leasing.
- Phone: +1 212 905 9150
- Email: david.grimes@alston.com
- Representing Dalian Wanda Group in its $1 billion purchase of Dick Clark productions.
- Represented BBC Worldwide in its investment in BritBox, a British content-focused SVOD platform with its joint venture partners.
- Represented Patheon Inc. (now part of Thermo Fisher Scientific), a publicly traded leading global provider of manufacturing and contract development services to the global pharmaceutical industry, in its $255 million acquisition of Banner Pharmacaps, a global specialty life sciences company.
- Represented Talecris Biotherapeutics, a biologics company, in its purchase of numerous blood plasma centers, its $1 billion IPO and related 144A debt offering.
- Represented ANV Holding B.V., a Dutch specialty insurer, in the U.S. aspects of its purchase of Flagstone Holdings (UK) Limited.
- Represented Bretèche Industrie (n/k/a LINXIS), then a portfolio company of Equistone Partners, in its first North American acquisition of Schick Solutions, an ingredient automation company.
David Grimes draws on over three decades of experience when helping clients with their cross border and domestic M&A, securities, commercial, and restructuring transactions. He supports companies and private equity funds in their acquisitions, dispositions, and joint ventures. He also represents venture funds in their investments, and financial institutions in their financing transactions and restructurings. David counsels clients in various industries, including media, life sciences, financial institutions, and industrials.
David previously co-founded an Am Law 100 firm’s Paris office and was the head of its cross-border transactions practice group. He has been recognized by Legal 500 US as a “Leading Lawyer” for M&A/Corporate & Commercial: M&A: middle market ($500m-$999m) from 2022-2024. David was also recognized by The M&A Advisor for participating in an acquisition that won its “Cross Border M&A Deal of the Year (Over $100mm - $250mm)” award in 2015.
Languages
- French
Bar Admissions
- New York
Education
- Emory University (J.D., 1987)
- The London School of Economics (M.Sc., 1984)
- William & Mary (B.A., 1983)
Memberships
- Anchor Health Initiative, co-founder and board member